Cannara BiotechLOVFF -4.84%84 Days Inventory is 307.33 as of Feb. 2026, which is 17% above its 10-year median of 262.01. GuruFocus rates LOVFF with a GF Score™ of 84/100 and a GF Value™ of $1.18 (Fairly Valued). The stock has 4 warning signs investors should review. Among 917 Drug Manufacturers companies, Cannara Biotech ranks worse than 81.68% on this metric.
The historical rank and industry rank for Cannara Biotech's Days Inventory or its related term are showing as below:
LOVFF'
s Days Inventory Range Over the Past 10 Years
Min: 168.95 Med: 262.01 Max: 334.06
Current: 282.82
During the past 8 years, Cannara Biotech's highest Days Inventory was 334.06. The lowest was 168.95. And the median was 262.01.
LOVFF's Days Inventory is ranked worse than 81.68% of 917
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs LOVFF: 282.82
Cannara Biotech's Days Inventory
increased
from Feb. 2025 (274.86) to Feb. 2026 (307.33).
It might indicate that Cannara Biotech's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Cannara Biotech's Inventory Turnover for the
three
months ended in Feb. 2026 was 0.30.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cannara Biotech's Inventory-to-Revenue for the
three
months ended in Feb. 2026 was 1.92.
Cannara Biotech (OTCPK:LOVFF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Cannara Biotech's Inventory Turnover for the
three
months ended in Feb. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cannara Biotech's Inventory to Revenue for the
three
months ended in Feb. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Cannara Biotech Days Inventory Related Terms
Cannara Biotech Days Inventory Historical Data
* Premium members only.
The historical data trend for Cannara Biotech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannara Biotech Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's Days Inventory distribution charts can be found below:
* The bar in red indicates where Cannara Biotech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannara Biotech (LOVFF) has a Days Inventory of 307.33 as of Feb. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cannara Biotech and its competitors. This is 17% above median its historical median of 262.01. Over the past decade, Cannara Biotech's Days Inventory has ranged from 168.95 to 334.06. According to the industry distribution chart, Cannara Biotech ranks #749 out of 917 companies in the Drug Manufacturers industry, placing it in the top 81.7%.
Is Cannara Biotech's Days Inventory too high?
Cannara Biotech's current Days Inventory of 307.33 is 17% above median its 10-year median of 262.01. Over the past 10 years, this metric has ranged from a low of 168.95 to a high of 334.06. The Drug Manufacturers industry median Days Inventory is 164.48. Cannara Biotech's value of 307.33 is 86.8% above this industry median. Based on the distribution chart, Cannara Biotech ranks #749 out of 917 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Cannara Biotech has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cannara Biotech's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cannara Biotech ranks #749 out of 917 companies for Days Inventory. This places Cannara Biotech in the lower half of its industry. The industry median Days Inventory is 164.48. Cannara Biotech's value of 307.33 is 86.8% above this benchmark. Historically, Cannara Biotech's own Days Inventory has ranged from 168.95 to 334.06 over the past decade. While the company's 10-year median is 262.01 vs. the industry median of 164.48, Cannara Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 917 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cannara Biotech's current Days Inventory of 307.33 is 86.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cannara Biotech and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannara Biotech's current Days Inventory is 307.33, which is 17% above median its own 10-year median of 262.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannara Biotech stock overvalued right now?
Based on GuruFocus' analysis, Cannara Biotech (LOVFF) is currently considered Fairly Valued. The stock's GF Value™ is $1.18, compared to a current price of $1.18 — trading right at its estimated fair value. The current Days Inventory is 307.33, which is 17% above median its 10-year median of 262.01 and 86.8% above the Drug Manufacturers industry median of 164.48. Cannara Biotech's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Cannara Biotech (LOVFF), the current Days Inventory is 307.33 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cannara Biotech (LOVFF) Overvalued in 2026?
Based on GuruFocus' analysis, Cannara Biotech stock appears to be undervalued.
The current stock price of $1.18 is trading 0% below its estimated GF Value™ of $1.18.
GuruFocus considers Cannara Biotech to be Fairly Valued.
Key valuation signals for LOVFF:
Days Inventory: 307.33 (17% above median its 10-year median of 262.01)
GF Value™: $1.18 vs. price of $1.18 (0% below fair value)
Industry Position: 86.8% above the Drug Manufacturers median (#749 of 917)
No single metric tells the full story. See the LOVFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .
84GF Score
Get the complete analysis for LOVFF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LOVFF has been successfully added to your 
